Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation

Published:2014-11 Issue:1 Volume:1329 Page:93-106
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Hanna Michael S.¹,Mohan Puneet²,Knabb Robert¹,Gupta Elora³,Frost Charles⁴,Lawrence John H.¹

Affiliation:

1. Global Clinical Research, Research & Development Bristol‐Myers Squibb Company Princeton New Jersey

2. Global Product Development PPD Rockville Maryland

3. Global Regulatory Affairs Otsuka Pharmaceutical Development & Commercialization, Inc Princeton New Jersey

4. Exploratory Clinical and Translational Research Bristol‐Myers Squibb Company Princeton New Jersey

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.12567

Reference41 articles.

1. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

2. Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States

3. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition);Singer D.E.;Chest,2008

4. Antithrombotic benefits and hemorrhagic risks of direct thrombin antagonists;Harker L.A.;Thromb. Haemost.,1995

5. Antithrombotic and Hemorrhagic Effects of DX-9065a, a Direct and Selective Factor Xa Inhibitor: Comparison with a Direct Thrombin Inhibitor and Antithrombin Ill-Dependent Anticoagulants

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Implications of Co‐administering Apixaban with Key Interacting Medications;Clinical Pharmacology in Drug Development;2024-07-24

2. An alternative synthetic strategy to construct apixaban analogues;Arkivoc;2024-07-07

3. Efficacy of Metoprolol and Apixaban in the treatment of cardiovascular diseases: A meta-analysis;Indian Journal of Pharmacy and Pharmacology;2024-01-15

4. Optimization for small volume of distribution leading to the discovery of apixaban;Overcoming Obstacles in Drug Discovery and Development;2023

5. Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients;Thrombosis and Haemostasis;2022-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3